196 related articles for article (PubMed ID: 24011515)
21. Clostridium perfringens delta toxin is sequence related to beta toxin, NetB, and Staphylococcus pore-forming toxins, but shows functional differences.
Manich M; Knapp O; Gibert M; Maier E; Jolivet-Reynaud C; Geny B; Benz R; Popoff MR
PLoS One; 2008; 3(11):e3764. PubMed ID: 19018299
[TBL] [Abstract][Full Text] [Related]
22. Chloroquine derivatives block the translocation pores and inhibit cellular entry of Clostridium botulinum C2 toxin and Bacillus anthracis lethal toxin.
Kreidler AM; Benz R; Barth H
Arch Toxicol; 2017 Mar; 91(3):1431-1445. PubMed ID: 27106023
[TBL] [Abstract][Full Text] [Related]
23. Evaluation of the anti-infectious properties of polyester vascular prostheses functionalised with cyclodextrin.
Jean-Baptiste E; Blanchemain N; Neut C; Chai F; Maton M; Martel B; Hildebrand H; Haulon S
J Infect; 2014 Feb; 68(2):116-24. PubMed ID: 24140067
[TBL] [Abstract][Full Text] [Related]
24. Genetic characteristics of toxigenic Clostridia and toxin gene evolution.
Popoff MR; Bouvet P
Toxicon; 2013 Dec; 75():63-89. PubMed ID: 23707611
[TBL] [Abstract][Full Text] [Related]
25. The designer proline-rich antibacterial peptide A3-APO prevents Bacillus anthracis mortality by deactivating bacterial toxins.
Otvos L; Flick-Smith H; Fox M; Ostorhazi E; Dawson RM; Wade JD
Protein Pept Lett; 2014 Apr; 21(4):374-81. PubMed ID: 24164262
[TBL] [Abstract][Full Text] [Related]
26. Prevalence and characteristics of bacteria and host factors in an outbreak situation of antibiotic-associated diarrhoea.
Ackermann G; Thomalla S; Ackermann F; Schaumann R; Rodloff AC; Ruf BR
J Med Microbiol; 2005 Feb; 54(Pt 2):149-153. PubMed ID: 15673508
[TBL] [Abstract][Full Text] [Related]
27. Dual effect of synthetic aminoglycosides: antibacterial activity against Bacillus anthracis and inhibition of anthrax lethal factor.
Fridman M; Belakhov V; Lee LV; Liang FS; Wong CH; Baasov T
Angew Chem Int Ed Engl; 2005 Jan; 44(3):447-52. PubMed ID: 15624157
[No Abstract] [Full Text] [Related]
28. A recombinant Bacillus anthracis strain producing the Clostridium perfringens Ib component induces protection against iota toxins.
Sirard JC; Weber M; Duflot E; Popoff MR; Mock M
Infect Immun; 1997 Jun; 65(6):2029-33. PubMed ID: 9169728
[TBL] [Abstract][Full Text] [Related]
29. Synthesis and SAR studies of novel benzodiazepinedione-based inhibitors of Clostridium difficile (C. difficile) toxin B (TcdB).
Letourneau JJ; Stroke IL; Hilbert DW; Cole AG; Sturzenbecker LJ; Marinelli BA; Quintero JG; Sabalski J; Li Y; Ma L; Pechik I; Stein PD; Webb ML
Bioorg Med Chem Lett; 2018 Dec; 28(23-24):3601-3605. PubMed ID: 30392779
[TBL] [Abstract][Full Text] [Related]
30. Similar frequency of detection of Clostridium perfringens enterotoxin and Clostridium difficile toxins in patients with antibiotic-associated diarrhea.
Abrahao C; Carman RJ; Hahn H; Liesenfeld O
Eur J Clin Microbiol Infect Dis; 2001 Sep; 20(9):676-7. PubMed ID: 11714055
[No Abstract] [Full Text] [Related]
31. Prevalence of Clostridium difficile toxins A and B and Clostridium perfringens enterotoxin A in stool samples of patients with antibiotic-associated diarrhea.
Heimesaat MM; Granzow K; Leidinger H; Liesenfeld O
Infection; 2005 Oct; 33(5-6):340-4. PubMed ID: 16258864
[TBL] [Abstract][Full Text] [Related]
32. Immunological and functional comparison between Clostridium perfringens iota toxin, C. spiroforme toxin, and anthrax toxins.
Perelle S; Scalzo S; Kochi S; Mock M; Popoff MR
FEMS Microbiol Lett; 1997 Jan; 146(1):117-21. PubMed ID: 8997715
[TBL] [Abstract][Full Text] [Related]
33. Mimicking an antimicrobial peptide polymyxin B by use of cyclodextrin.
Yamamura H; Suzuki K; Uchibori K; Miyagawa A; Kawai M; Ohmizo C; Katsu T
Chem Commun (Camb); 2012 Jan; 48(6):892-4. PubMed ID: 22143262
[TBL] [Abstract][Full Text] [Related]
34. Ebselen and analogs as inhibitors of Bacillus anthracis thioredoxin reductase and bactericidal antibacterials targeting Bacillus species, Staphylococcus aureus and Mycobacterium tuberculosis.
Gustafsson TN; Osman H; Werngren J; Hoffner S; Engman L; Holmgren A
Biochim Biophys Acta; 2016 Jun; 1860(6):1265-71. PubMed ID: 26971857
[TBL] [Abstract][Full Text] [Related]
35. METABOLISM OF MICROORGANISMS AS RELATED TO THEIR PATHOGENICITY.
PANOS C; AJL SJ
Annu Rev Microbiol; 1963; 17():297-328. PubMed ID: 14147454
[No Abstract] [Full Text] [Related]
36. Symmetry complementarity-guided design of anthrax toxin inhibitors based on β-cyclodextrin: Synthesis and relative activities of face-selective functionalized polycationic clusters.
Díaz-Moscoso A; Méndez-Ardoy A; Ortega-Caballero F; Benito JM; Ortiz Mellet C; Defaye J; Robinson TM; Yohannes A; Karginov VA; García Fernández JM
ChemMedChem; 2011 Jan; 6(1):181-92. PubMed ID: 21140396
[TBL] [Abstract][Full Text] [Related]
37. Disarming Pore-Forming Toxins with Biomimetic Nanosponges in Intraocular Infections.
Coburn PS; Miller FC; LaGrow AL; Land C; Mursalin H; Livingston E; Amayem O; Chen Y; Gao W; Zhang L; Callegan MC
mSphere; 2019 May; 4(3):. PubMed ID: 31092603
[TBL] [Abstract][Full Text] [Related]
38. Prevalence of Clostridium perfringens toxin in patients suspected of having antibiotic-associated diarrhea.
Kim YJ; Kim SH; Ahn J; Cho S; Kim D; Kim K; Lee H; Son H; Lee HJ; Yong D; Choi JY; Kim HR; Shin JH
Anaerobe; 2017 Dec; 48():34-36. PubMed ID: 28655582
[TBL] [Abstract][Full Text] [Related]
39. Synthesis of antimicrobial cyclodextrins bearing polyarylamino and polyalkylamino groups via click chemistry for bacterial membrane disruption.
Yamamura H; Sugiyama Y; Murata K; Yokoi T; Kurata R; Miyagawa A; Sakamoto K; Komagoe K; Inoue T; Katsu T
Chem Commun (Camb); 2014 May; 50(41):5444-6. PubMed ID: 24575430
[TBL] [Abstract][Full Text] [Related]
40. A prospective study of the roles of clostridium difficile and enterotoxigenic Clostridium perfringens in equine diarrhoea.
Weese JS; Staempfli HR; Prescott JF
Equine Vet J; 2001 Jul; 33(4):403-9. PubMed ID: 11469775
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
